Sigrid Therapeutics

About:

Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.

Website: http://www.sigridthx.com/

Twitter/X: sigridthx

Top Investors: Almi Invest, Joyance Partners, Social Starts, Irrus Investments, 3T Invest

Description:

Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.

Total Funding Amount:

$32.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Stockholm, Stockholms Lan, Sweden

Founded Date:

2014-01-01

Founders:

Sana Alajmovic, Tore Bengtsson

Number of Employees:

11-50

Last Funding Date:

2023-10-31

IPO Status:

Private

Industries: